Nature's Miracle Holding Inc. NMHI
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $1.1M
- P/E
- 0.0×
Follow NMHI
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.08 | 0.65 | 0.94 | 0.00 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(1.32) | (1.63) | (0.75) | 0.00 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.19 | 4.52 | 5.98 | 15.59 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(1.23) | (2.24) | (2.61) | (2.11) | |
EV/FCF |
(1.23) | (2.24) | (2.60) | (1.77) | |
Quick Ratio |
0.10 | 0.08 | 0.01 | 0.02 | |
Current Ratio |
0.14 | 0.14 | 0.04 | 0.07 | |
Net Debt/EBITDA |
(5.97) | (8.67) | (3.31) | (16.54) | |
Debt/Assets |
64.61% | 38.32% | 43.45% | 49.25% | |
Debt/Equity |
(0.34) | (0.94) | (0.70) | (1.14) | |
Asset Turnover |
0.47 | 0.12 | 0.11 | 0.04 | |
Operating CF/Net income |
0.18 | 0.41 | 0.36 | (0.56) | |
Capex/Depreciation |
0.00 | 0.08 | 0.00 | (2.22) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
211.90% | 1,664.64% | 1,690.91% | 2,619.71% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
12.60% | 116.16% | 140.78% | 251.92% | |
Graham Net Nets |
(55.82) | (19.91) | (19.61) | 0.00 | |
Graham Number |
22.08 | 9.73 | 3.88 | 0.66 | |
Earnings Yield |
(10,827.14%) | (3,897.15%) | (712.91%) | 0.00% | |
Free Cash Flow Yield |
(1,228.15%) | (312.06%) | (244.33%) | 0.00% | |
Revenue per Share |
0.08 | 0.01 | 0.01 | 0.00 | |
Operating CF per Share |
(0.05) | (0.08) | (0.15) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Free Cash Flow per Share |
(0.05) | (0.08) | (0.15) | (0.02) | |
Cash per Share |
0.00 | 0.01 | 0.01 | 0.00 | |
Shareholders Equity per Share |
(2.86) | (0.83) | (0.85) | (0.06) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(2.86) | (0.83) | (0.85) | (0.06) | |
Free Cash Flow |
(0.31) | (0.87) | (2.18) | (2.61) | |
Working Capital |
(17.52) | (19.75) | (22.30) | (17.62) | |
Capital Expenditures |
— | 0.03 | 0.00 | (1.00) | |
Net Current Asset Value |
(23.19) | (29.15) | (32.20) | (29.52) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | (0.36) | 0.00 | 24.04 | |
Net Profit Margin |
(365.89%) | (3,048.07%) | (7,561.74%) | 6,839.66% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.40 | 2.98 | 1.48 | 1.42 | |
Average Payables |
10.62 | 9.81 | 10.37 | 6.82 | |
Average Inventory |
2.44 | 1.99 | — | — | |
Average Assets |
11.15 | 18.45 | 15.86 | 15.68 | |
Average Common Equity |
(15.05) | (10.60) | (13.54) | (12.33) |
Columns are period end dates